ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Response Genetics Inc (CE)

Response Genetics Inc (CE) (RGDXQ)

0,000001
0,00
(0,00%)
Geschlossen 28 Januar 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,000001
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,000001 52-Wochen-Bereich 0,000001
Handelsende
0,000001
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
30.000
Finanzvolumen
-
VWAP
-

RGDXQ Neueste Nachrichten

Great Basin Welcomes Kirk Calhoun to Board of Directors

Great Basin Welcomes Kirk Calhoun to Board of Directors Mr. Calhoun Will Serve as Head of the Audit Committee PR Newswire SALT LAKE CITY, June 2, 2015 SALT LAKE CITY, June 2, 2015 /PRNewswire/...

Response Genetics, Inc. Announces First Quarter 2015 Financial Results

LOS ANGELES, May 14, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. to Release First Quarter 2015 Financial Results and Host Conference Call on May 14, 2015

LOS ANGELES, May 7, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2014 Financial Results

LOS ANGELES, March 31, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 31, 2...

LOS ANGELES, March 19, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Sympo...

LOS ANGELES, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics Secures New York State Department of Health Approval for the Company's ResponseDX(R) Testing Services

LOS ANGELES, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics Launches New Test for Cancer Immunotherapy Drug Development

LOS ANGELES, June 16, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

FDA-Cleared, Medicare-Reimbursed, ResponseDX: Tissue of Origin(TM) Test Added to National Institute of Health's (NIH) Genetic...

LOS ANGELES, June 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

Response Genetics Expands Distribution of ResponseDX(R) Product Portfolio Into International Markets

LOS ANGELES, May 14, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-6300001.0E-6CS
26001.0E-61.0E-61.0E-678751.0E-6CS
52001.0E-61.0E-61.0E-645001.0E-6CS
156-9.9E-5-990.00010.00011.0E-662413.18E-6CS
260-0.002899-99.96551724140.00290.04461.0E-61161260.00602297CS

RGDXQ - Frequently Asked Questions (FAQ)

What is the current Response Genetics (CE) share price?
The current share price of Response Genetics (CE) is US$ 0,000001
What is the 1 year trading range for Response Genetics (CE) share price?
Response Genetics (CE) has traded in the range of US$ 0,000001 to US$ 0,000001 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TGICTriad Guaranty Inc (CE)
US$ 0,05
(49.900,00%)
1,4k
NOUVNouveau Life Pharmaceuticals Inc (PK)
US$ 0,0002
(19.900,00%)
4,31M
ATYGAtlas Technology Group Inc (PK)
US$ 0,0002
(19.900,00%)
9k
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0,0002
(19.900,00%)
255
ONCIOn4 Communications Inc (PK)
US$ 0,0001
(9.900,00%)
16,82M
SPECSpectaire Holdings Inc (CE)
US$ 0,000001
(-99,95%)
1,99k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0,000001
(-99,89%)
452
FUVVArcimoto Inc (CE)
US$ 0,000001
(-99,50%)
336
SAFSSafer Shot Inc (CE)
US$ 0,000001
(-99,00%)
2M
JAMNJammin Java Corp (PK)
US$ 0,000001
(-99,00%)
39k
TKMOTekumo Inc (PK)
US$ 0,0004
(0,00%)
244,5M
HMBLHUMBL Inc (PK)
US$ 0,00075
(-6,25%)
219,57M
PDGOParadigm Oil and Gas Inc (PK)
US$ 0,0002
(33,33%)
215,18M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,000001
(-99,00%)
195,11M
DPLSDarkPulse Inc (PK)
US$ 0,0006
(-14,29%)
182,43M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht